• News
  • Now published: first independent comparison o...
News - published on 23 Jan 2018

Now published: first independent comparison of pharma companies’ efforts to address drug-resistant infections

Amsterdam, Davos, 23 January 2018 – The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, finds that companies are developing new drugs as well as dismantling the incentives that encourage sales staff to oversell antibiotics, setting limits on the concentration of antibiotics in factory wastewater released into the environment, and tracking the spread of superbugs.

Explore further

Back to top |